Liver fibrosis market
Kanishk Kumar
0
41
Share this Post to earn Money ( Upto ₹100 per 1000 Views )
The liver fibrosis market is expanding due to rising cases of chronic liver diseases like hepatitis and non-alcoholic fatty liver disease (NAFLD), along with advancements in non-invasive diagnostic tools. Key players such as Madrigal Pharmaceuticals, Akero Therapeutics, Sagimet Biosciences, and 89bio are developing promising therapies targeting fibrosis pathways. The market is projected to grow significantly, driven by increased awareness, early diagnosis, and the emergence of effective treatments.
Access Market Report: https://shorturl.at/7M2K7
